Skip to content

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS
Researchers document peripheral T-cell lymphomas across Latin America
How do lifestyle factors play a role in the response to CAR-T therapy?
Patient case highlights secondary tumor after CAR-T treatment for myeloma
Olutasidenib plus azacitidine show ‘durable’ responses in relapsed or refractory IDH1-mutated AML

Join SOHO

Follow Us :

Home
About
Society Updates
- Society Updates
- Join SOHO
Resources
News
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Roundtable Discussions
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Researchers document peripheral T-cell lymphomas across Latin America

Cellular Therapy

Researchers document peripheral T-cell lymphomas across Latin America

Leukemia

Researchers document peripheral T-cell lymphomas across Latin America

Lymphoma

Researchers document peripheral T-cell lymphomas across Latin America

Multiple Myeloma

Researchers document peripheral T-cell lymphomas across Latin America

Myelodysplastic Syndromes

Researchers document peripheral T-cell lymphomas across Latin America

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 18, 2025

Home
About
Society Updates
- Society Updates
- Join SOHO
Resources
News
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Roundtable Discussions
Subscribe

SOHO Insider News Lymphoma

Lymphoma News

Latin America flag

Lymphoma T-Cell Lymphoma

Researchers document peripheral T-cell lymphomas across Latin America

by Leah Sherwood
March 14, 2025
0 Comments

TNF-a

Leukemia Lymphoma

Long-term use of TNF inhibitors for psoriasis, RA may increase risk for leukemia, lymphoma but not other cancers

by SOHO Insider Editors
March 10, 2025
0 Comments

Megan Melody, MD

Cellular Therapy Lymphoma News Society Updates

SOHO Young Investigator Spotlight: Meet Megan Melody, MD

by Leah Sherwood
March 7, 2025
0 Comments

PET scan

Lymphoma News

Interim PET scan after 4 treatment cycles predicts outcomes in primary mediastinal B-cell lymphoma patients

by SOHO Insider Editors
March 3, 2025
0 Comments

Lymphoma

FDA clears Ventana hematopathology test for diagnosing BCL

by SOHO Insider Editors
March 3, 2025
0 Comments

Lymphoma

FDA clears IND for novel relapsed or refractory NHL therapy

by SOHO Insider Editors
February 27, 2025
0 Comments

Lymphoma

Japan regulatory body approves epcoritamab for relapsed or refractory follicular lymphoma

by SOHO Insider Editors
February 24, 2025
0 Comments

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Abstract submissions now open for SOHO 2025

by Leah Sherwood
February 14, 2025
0 Comments

Chimeric antigen therapy

Lymphoma

CAR-T treatment access, timeliness remain issues for patients with NHL

by SOHO Insider Editors
February 11, 2025
0 Comments

Chronic Lymphocytic Leukemia Indolent B-Cell Lymphomas Lymphoma Multiple Myeloma

Is a stronger flu vaccine better for blood cancer patients?

by Leah Sherwood
February 3, 2025
0 Comments

1
2
3

POPULAR NEWS

MyeloMatch, NCI

Acute Myeloid Leukemia , Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

Imatinib

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

Circulating tumor DNA

Aggressive B-Cell Lymphomas , Lymphoma , News

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

January 9, 2025

Top Categories

Cellular Therapy

7

Leukemia

24

Lymphoma

21

Multiple Myeloma

17

Myelodysplastic Syndromes

11

Myeloproliferative Neoplasms

7

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

Researchers document peripheral T-cell lymphomas across Latin America

Cellular Therapy

Researchers document peripheral T-cell lymphomas across Latin America

Leukemia

Researchers document peripheral T-cell lymphomas across Latin America

Lymphoma

Researchers document peripheral T-cell lymphomas across Latin America

Multiple Myeloma

Researchers document peripheral T-cell lymphomas across Latin America

Myelodysplastic Syndromes

Researchers document peripheral T-cell lymphomas across Latin America

Myeloproliferative Neoplasms

Subscribe

Recent Posts

European Commission

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Latin America flag

Researchers document peripheral T-cell lymphomas across Latin America

Fried salmon steak with vegetables on wooden table

How do lifestyle factors play a role in the response to CAR-T therapy?

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.